| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 08, 2024 | Option Exercise | $123.14 | 909 | 111,934 | 68,073 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 07, 2024 | Option Exercise | $120.49 | 512 | 61,691 | 68,982 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 04, 2024 | Option Exercise | $125.32 | 1,728 | 216,553 | 69,494 | Mar 06, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2024 | Option Exercise | $126.19 | 778 | 98,176 | 65,222 | Mar 05, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Nov 17, 2023 | Option Exercise | $82.98 | 4,508 | 374,074 | 65,751 | Nov 20, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 08, 2023 | Option Exercise | $153.19 | 912 | 139,709 | 70,170 | Mar 10, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 06, 2023 | Option Exercise | $157.21 | 1,134 | 178,276 | 66,582 | Mar 08, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2023 | Option Exercise | $147.57 | 522 | 77,032 | 67,716 | Mar 03, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Nov 17, 2022 | Option Exercise | $108.52 | 4,211 | 456,978 | 67,998 | Nov 21, 2022, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 04, 2022 | Option Exercise | $79.20 | 1,216 | 96,307 | 64,111 | Mar 08, 2022, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2022 | Option Exercise | $75.05 | 572 | 42,929 | 65,327 | Mar 01, 2022, 08:03 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Nov 24, 2021 | Buy | $79.33 | 3,780 | 299,867 | 65,678 | Nov 29, 2021, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Chief Scientific Officer | Feb 28, 2021 | Option Exercise | $86.97 | 565 | 49,138 | 6,604 | Mar 10, 2021, 08:01 PM |
Menu